Siroz olgularında dinamik BT bulgularının klinik ve laboratuvar bulgularıyla ilişkisi

















































28. Gennaro DAmico1, Guadalupe Garcia-Tsao, Luigi Pagliaro. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. Journal of Hepatology 2006; 217-231. 29. Ho YP, Chen YC, Yang C, et al. Outcome Prediction for Critically Ill Cirrhotic Patients: A Comparison of APACHE II and Child-Pugh Scoring Systems. Journal of Intensive Care Medicine. 2004; 19:105-110. 30. Sherck JP, Shatney CH. ICU scoring systems do not allow prediction of patient outcomes or comparison of ICU performance. Crit Care Clin 1996; 12:515-523. 31. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871. 32. Cholongıtas E, Senzolo M, Patch D. et al. Burroughs Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics. Aliment Pharmacol Ther. 2004; 24:453464. 33. Northup PG, Wanamaker RC, Lee VD, Adams RB, Berg CL. Model for End-Stage Liver Disease (MELD) Predicts Nontransplant Surgical Mortality in Patients With Cirrhosis. Chest.2005; 242:244-251 34. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with endstage liver disease._comment_. Hepatology. 2001; 33:464-470. 35. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94:153-156 36. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998; 28:751-755 37. Bruix, J, Sherman, M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236. 38. Llovet, JM, Bustamante, J, Castells, A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma. Rationale for the design and evaluation of therapeutic trials. Hepatology1999; 29:62-67.
33



44. SAYFAYA BENZER SAYFALAR

Yoğun bakıma yatırılan sirozlu olgularda prognozu belirleyen risk faktörleri - Sayfa 61
57. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871. 58. Cholongıtas E, Senzolo M, Patch D. et al. Burroughs Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics. Aliment Pharmacol Ther. 2004; 24:453-464. 59. Northup PG, Wanamaker RC,...
Yoğun bakım ünitesinde takip edilen hepatik ensefalopatili hastalarda mortaliteyi etkileyen faktörler - Sayfa 70
84. Olson JC, Wendon JA, Kramer DJ et al: İntensive care of the patient with cirrhosis. Hepatology 2011; 54: 1864-72. 85. Karabıyık L. Yoğun Bakımda Skorlama Sistemleri. Yoğun Bakım Dergisi 2010; 9: 129-143. 86. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: A severity of disease classification system. Critical Care Medicine 1985; 13:818-829. 87. Kalaycıoğlu N, Kaplan Me, Ünsel M. Yoğun Bakı...
Yoğun bakıma yatırılan sirozlu olgularda prognozu belirleyen risk faktörleri - Sayfa 62
70. Teres D, Lemeshow S. Why severity models should be used with caution. Crit Care Clin 1994; 10:93-110. 71. Rafkin HS, Hoyt JW. Objective data and quality assurance programs. Current and future trends. Crit Care Clin 1994; 10:157-177. 72. Vincent JL, Ferreira F, Moreno R. Scoring systems for assessing organ dysfunction and survival. Crit Care Clin 2000; 16:353-366. 73. Singh N, Gayowski T, Wa...

44. SAYFADAKI ANAHTAR KELIMELER

patients
care
systems
scoring
patient
comparison


44. SAYFA ICERIGI

28. Gennaro DAmico1, Guadalupe Garcia-Tsao, Luigi Pagliaro. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. Journal of Hepatology 2006; 217-231. 29. Ho YP, Chen YC, Yang C, et al. Outcome Prediction for Critically Ill Cirrhotic Patients: A Comparison of APACHE II and Child-Pugh Scoring Systems. Journal of Intensive Care Medicine. 2004; 19:105-110. 30. Sherck JP, Shatney CH. ICU scoring systems do not allow prediction of patient outcomes or comparison of ICU performance. Crit Care Clin 1996; 12:515-523. 31. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871. 32. Cholongıtas E, Senzolo M, Patch D. et al. Burroughs Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics. Aliment Pharmacol Ther. 2004; 24:453464. 33. Northup PG, Wanamaker RC, Lee VD, Adams RB, Berg CL. Model for End-Stage Liver Disease (MELD) Predicts Nontransplant Surgical Mortality in Patients With Cirrhosis. Chest.2005; 242:244-251 34. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with endstage liver disease._comment_. Hepatology. 2001; 33:464-470. 35. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94:153-156 36. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998; 28:751-755 37. Bruix, J, Sherman, M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236. 38. Llovet, JM, Bustamante, J, Castells, A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma. Rationale for the design and evaluation of therapeutic trials. Hepatology1999; 29:62-67.
33

İlgili Kaynaklar







single.php